v3.26.1
Unaudited condensed consolidated interim statement of comprehensive loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
Research and development [1] $ (12,399) $ (8,958) $ (24,778) $ (16,810)
General and administration (7,056) (5,746) (13,426) (10,626)
Loss from operations (19,455) (14,704) (38,204) (27,436)
Finance income 2,657 3,074 4,851 5,833
Finance expense (83) (174) (167) (352)
Movement of expected credit loss 7 13 8 (6)
Foreign exchange gain/(loss) 1,728 2,502 (601) 1,860
Total other income 4,309 5,415 4,091 7,335
Loss before tax (15,146) (9,289) (34,113) (20,101)
Tax charge/(credit) 0 0 0 0
Loss for the period (15,146) (9,289) (34,113) (20,101)
Items that may be reclassified to profit or loss        
Fair value movement on marketable securities (45) (82) (129) (22)
Currency translation adjustment (2,561) 457 (1,739) 989
Total comprehensive loss for the period (17,752) (8,914) (35,981) (19,134)
Attributable to owners:        
Loss for the period (15,146) (9,289) (34,113) (20,101)
Total comprehensive loss for the period $ (17,752) $ (8,914) $ (35,981) $ (19,134)
Loss per share        
Basic loss per share (in dollars per share) $ (0.23) $ (0.15) $ (0.53) $ (0.33)
Diluted loss per share (in dollars per share) $ (0.23) $ (0.15) $ (0.53) $ (0.33)
[1] Depreciation and other expenses have been reclassified to external research and development expenses and depreciation has been reclassified to external costs for all periods presented as it provides more relevant information.